301089 拓新药业
已收盘 11-05 15:00:00
资讯
新帖
简况
拓新药业(301089)3774.65万股限售股将于10月28日解禁,占总股本29.83%
证券之星 · 10-28
拓新药业(301089)3774.65万股限售股将于10月28日解禁,占总股本29.83%
拓新药业(301089)2024年三季报简析:净利润减100.85%,盈利能力上升
证券之星 · 10-27
拓新药业(301089)2024年三季报简析:净利润减100.85%,盈利能力上升
拓新药业(301089)10月18日股东户数1.92万户,较上期减少2.7%
证券之星 · 10-26
拓新药业(301089)10月18日股东户数1.92万户,较上期减少2.7%
拓新药业(301089.SZ)3774.65万股限售股将于10月28日上市流通
智通财经 · 10-24
拓新药业(301089.SZ)3774.65万股限售股将于10月28日上市流通
拓新药业(301089)10月10日股东户数1.97万户,较上期减少9.21%
证券之星 · 10-15
拓新药业(301089)10月10日股东户数1.97万户,较上期减少9.21%
【猴痘概念股大涨 合富中国、亚太药业回应】金十数据8月27日讯,猴痘概念早盘拉升,海辰药业20CM涨停,亚太药业、合富中国10CM涨停,透景生命、拓新药业等跟涨。
美港电讯 · 08-27
【猴痘概念股大涨 合富中国、亚太药业回应】金十数据8月27日讯,猴痘概念早盘拉升,海辰药业20CM涨停,亚太药业、合富中国10CM涨停,透景生命、拓新药业等跟涨。
存在扩散风险!WHO启动全球战略准备,猴痘概念股应声大涨
格隆汇 · 08-27
存在扩散风险!WHO启动全球战略准备,猴痘概念股应声大涨
A股猴痘概念早盘冲高,亚太药业、合富中国拉升涨停,海辰药业涨超10%,透景生命、拓新药业、普利制药、科华生物等跟涨。消息面上,世卫组织启动全球战略准备和应对计划,以遏制猴痘疫情蔓延。
美港电讯 · 08-27
A股猴痘概念早盘冲高,亚太药业、合富中国拉升涨停,海辰药业涨超10%,透景生命、拓新药业、普利制药、科华生物等跟涨。消息面上,世卫组织启动全球战略准备和应对计划,以遏制猴痘疫情蔓延。
拓新药业(301089)2024年中报简析:净利润减100.57%,三费占比上升明显
证券之星 · 08-25
拓新药业(301089)2024年中报简析:净利润减100.57%,三费占比上升明显
拓新药业(301089)8月9日股东户数2.17万户,较上期减少6.17%
证券之星 · 08-24
拓新药业(301089)8月9日股东户数2.17万户,较上期减少6.17%
图解拓新药业中报:第二季度单季净利润同比减173.62%
证券之星 · 08-24
图解拓新药业中报:第二季度单季净利润同比减173.62%
拓新药业(301089.SZ)发布上半年业绩,净亏损177.93万元,由盈转亏
智通财经网 · 08-23
拓新药业(301089.SZ)发布上半年业绩,净亏损177.93万元,由盈转亏
拓新药业最新公告:2024年上半年净利润亏损177.93万元
证券之星 · 08-23
拓新药业最新公告:2024年上半年净利润亏损177.93万元
拓新药业:公司产品四乙酰核糖、烟酰胺核苷(NR)可作为中间体,用于下游NMN的生产
证券之星 · 08-14
拓新药业:公司产品四乙酰核糖、烟酰胺核苷(NR)可作为中间体,用于下游NMN的生产
09:25 三大指数集体低开,沪指低开0.4%,深成指低开0.84%,创业板指低开0.95% 09:28 智能驾驶、网约车概念股开盘下挫,锦江在线、星网宇达双双跌停,雷尔伟、安凯客车、金龙汽车、启明信息等跌幅居前 09:32 光刻机、光刻胶概念逆势走强,京华激光涨停,蓝英装备涨超10%,国林科技、芯源微、富创精密、张江高科等涨幅靠前 09:59 智能网约车概念探底回升,天迈科技涨近15%,此前兴民智通、龙江交通涨停,大众交通、动力新科、力帆科技、豪恩汽电涨幅靠前 09:59 创业板指拉升翻红,沪指、深成指跌幅有所收窄,光刻机、医药等方向涨幅居前,沪深京三市上涨个股近800只,宁德时代、中国移动、中国石化、比亚迪、迈瑞医疗等权重股冲高 10:14 医药医疗股震荡反弹,河化股份拉升封板,拓新药业涨超14%,海普瑞、粤万年青、同仁堂、康缘药业等跟涨 10:47 半导体芯片股震荡走低,淳中科技跌超8%,南芯科技、芯海科技、蓝箭电子、希荻微、力芯微、必易微、大为股份、德明利、兆易创新等十余股跌超6% 10:58 光伏、储能板块逆势活跃,阿特斯涨超10%,天宸股份此前涨停,上能电气、德业股份、仕净科技、锦浪科技涨幅靠前
华尔街见闻 · 07-18
09:25 三大指数集体低开,沪指低开0.4%,深成指低开0.84%,创业板指低开0.95% 09:28 智能驾驶、网约车概念股开盘下挫,锦江在线、星网宇达双双跌停,雷尔伟、安凯客车、金龙汽车、启明信息等跌幅居前 09:32 光刻机、光刻胶概念逆势走强,京华激光涨停,蓝英装备涨超10%,国林科技、芯源微、富创精密、张江高科等涨幅靠前 09:59 智能网约车概念探底回升,天迈科技涨近15%,此前兴民智通、龙江交通涨停,大众交通、动力新科、力帆科技、豪恩汽电涨幅靠前 09:59 创业板指拉升翻红,沪指、深成指跌幅有所收窄,光刻机、医药等方向涨幅居前,沪深京三市上涨个股近800只,宁德时代、中国移动、中国石化、比亚迪、迈瑞医疗等权重股冲高 10:14 医药医疗股震荡反弹,河化股份拉升封板,拓新药业涨超14%,海普瑞、粤万年青、同仁堂、康缘药业等跟涨 10:47 半导体芯片股震荡走低,淳中科技跌超8%,南芯科技、芯海科技、蓝箭电子、希荻微、力芯微、必易微、大为股份、德明利、兆易创新等十余股跌超6% 10:58 光伏、储能板块逆势活跃,阿特斯涨超10%,天宸股份此前涨停,上能电气、德业股份、仕净科技、锦浪科技涨幅靠前
医药医疗股震荡反弹,河化股份拉升封板,拓新药业涨超14%,海普瑞、粤万年青、同仁堂、康缘药业等跟涨。
华尔街见闻 · 07-18
医药医疗股震荡反弹,河化股份拉升封板,拓新药业涨超14%,海普瑞、粤万年青、同仁堂、康缘药业等跟涨。
新冠特效药概念明显异动,拓新药业一度冲板,海辰药业大涨8%,博瑞医药、红日药业、奥翔药业跟涨。
智通财经 · 07-18
新冠特效药概念明显异动,拓新药业一度冲板,海辰药业大涨8%,博瑞医药、红日药业、奥翔药业跟涨。
拓新药业:公司2024年6月28日股东人数请您届时查看公司2024年半年度报告
证券之星 · 07-08
拓新药业:公司2024年6月28日股东人数请您届时查看公司2024年半年度报告
拓新药业:截至2024年6月20日,公司股东户数22,784户
证券之星 · 06-26
拓新药业:截至2024年6月20日,公司股东户数22,784户
拓新药业:截至2024年5月31日,公司股东户数22,702户
证券之星 · 06-03
拓新药业:截至2024年5月31日,公司股东户数22,702户
加载更多
公司概况
公司名称:
拓新药业集团股份有限公司
所属行业:
医药制造业
上市日期:
2021-10-27
主营业务:
拓新药业集团股份有限公司是集化学合成、生物发酵核苷(酸)类原料药及医药中间体的研发、生产及销售为一体的高新技术企业。主要产品有嘧啶系列、嘌呤系列、核苷酸系列、核苷系列等多个系列核苷(酸)类产品,包括胞磷胆碱钠、利巴韦林、肌苷、阿昔洛韦、胞嘧啶、5-氟胞嘧啶、胞苷等原料药及医药中间体,主要涵盖抗病毒、抗肿瘤和神经系统用药领域。被认定为“国家高技术产业示范工程”,获得国家科学技术进步二等奖等重大科技奖项。公司及子公司已获得境内授权专利 9 项。
发行价格:
19.11
{"stockData":{"symbol":"301089","market":"SZ","secType":"STK","nameCN":"拓新药业","latestPrice":33.3,"timestamp":1730790180000,"preClose":32.57,"halted":0,"volume":3425745,"delay":0,"floatShares":90975500,"shares":127000000,"eps":-0.5751,"marketStatus":"已收盘","marketStatusCode":5,"change":0.73,"latestTime":"11-05 15:00:00","open":32.41,"high":33.37,"low":32.02,"amount":113000000,"amplitude":0.0414,"askPrice":33.3,"askSize":328,"bidPrice":33.29,"bidSize":158,"shortable":0,"etf":0,"ttmEps":-0.5751,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1730856600000},"adr":0,"adjPreClose":32.57,"symbolType":"stock","openAndCloseTimeList":[[1730770200000,1730777400000],[1730782800000,1730790000000]],"highLimit":35.83,"lowLimit":29.31,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":126544500,"pbRate":2.63,"roa":"--","roe":"--","epsLYR":1.93,"committee":-0.222108,"marketValue":4214000000,"floatMarketCap":3029000000,"peRate":-57.902973,"changeRate":0.0224,"turnoverRate":0.0377,"status":0},"requestUrl":"/m/hq/s/301089","defaultTab":"news","newsList":[{"id":"2478113525","title":"拓新药业(301089)3774.65万股限售股将于10月28日解禁,占总股本29.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478113525","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478113525?lang=zh_cn&edition=full","pubTime":"2024-10-28 08:02","pubTimestamp":1730073777,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息整理,拓新药业于10月28日将有3774.65万股限售股份解禁,为公司首发原股东限售股份,占公司总股本29.83%。最近一年内,该股累计解禁54.45万股,占总股本的0.43%。本次解禁后,公司还有3556.9万股限售股份,占总股本28.11%。拓新药业主营业务:核苷(酸)类原料药及医药中间体的研发、生产及销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102800001203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301089"],"gpt_icon":0},{"id":"2478849471","title":"拓新药业(301089)2024年三季报简析:净利润减100.85%,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2478849471","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478849471?lang=zh_cn&edition=full","pubTime":"2024-10-27 11:01","pubTimestamp":1729998102,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期拓新药业发布2024年三季报。截至本报告期末,公司营业总收入3.26亿元,同比下降56.34%,归母净利润-265.38万元,同比下降100.85%。按单季度数据看,第三季度营业总收入1.07亿元,同比上升20.02%,第三季度归母净利润-87.45万元,同比下降123.91%。本报告期拓新药业盈利能力上升,毛利率同比增幅87.64%,净利率同比增幅151.58%。去年的净利率为29.09%,算上全部成本后,公司产品或服务的附加值高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102700011481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301089"],"gpt_icon":0},{"id":"2478894291","title":"拓新药业(301089)10月18日股东户数1.92万户,较上期减少2.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478894291","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478894291?lang=zh_cn&edition=full","pubTime":"2024-10-26 17:04","pubTimestamp":1729933482,"startTime":"0","endTime":"0","summary":"证券之星消息,近日拓新药业披露,截至2024年10月18日公司股东户数为1.92万户,较10月10日减少532.0户,减幅为2.7%。在化学制药行业个股中,拓新药业股东户数低于行业平均水平,截至10月18日,化学制药行业平均股东户数为3.13万户。从股价来看,2024年10月10日至2024年10月18日,拓新药业区间跌幅为3.46%,在此期间股东户数减少532.0户,减幅为2.7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102600008667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301089","BK0239"],"gpt_icon":0},{"id":"2477506304","title":"拓新药业(301089.SZ)3774.65万股限售股将于10月28日上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2477506304","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477506304?lang=zh_cn&edition=full","pubTime":"2024-10-24 17:20","pubTimestamp":1729761631,"startTime":"0","endTime":"0","summary":"智通财经APP讯,拓新药业(301089.SZ)公告,公司首次公开发行前已发行股份本次上市流通数量为3774.65万股,占公司股本总数的29.83%,上市流通日期为2024年10月28日(星期一)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1198872.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301089","BK0239"],"gpt_icon":0},{"id":"2475259015","title":"拓新药业(301089)10月10日股东户数1.97万户,较上期减少9.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475259015","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475259015?lang=zh_cn&edition=full","pubTime":"2024-10-15 17:05","pubTimestamp":1728983102,"startTime":"0","endTime":"0","summary":"证券之星消息,近日拓新药业披露,截至2024年10月10日公司股东户数为1.97万户,较8月9日减少2001.0户,减幅为9.21%。在化学制药行业个股中,拓新药业股东户数低于行业平均水平,截至10月10日,化学制药行业平均股东户数为3.2万户。从股价来看,2024年8月9日至2024年10月10日,拓新药业区间涨幅为8.38%,在此期间股东户数减少2001.0户,减幅为9.21%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101500027900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301089","BK0239"],"gpt_icon":0},{"id":"2462186766","title":"【猴痘概念股大涨 合富中国、亚太药业回应】金十数据8月27日讯,猴痘概念早盘拉升,海辰药业20CM涨停,亚太药业、合富中国10CM涨停,透景生命、拓新药业等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2462186766","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462186766?lang=zh_cn&edition=full","pubTime":"2024-08-27 12:51","pubTimestamp":1724734283,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["300584","BK0239","BK0046","BK0042","002370","301089","BK0132","BK0250","603122","300642"],"gpt_icon":0},{"id":"2462900923","title":"存在扩散风险!WHO启动全球战略准备,猴痘概念股应声大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2462900923","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462900923?lang=zh_cn&edition=full","pubTime":"2024-08-27 11:33","pubTimestamp":1724729600,"startTime":"0","endTime":"0","summary":"新毒株出现","market":"sg","thumbnail":"https://img3.gelonghui.com/b4c49-6ca0ab1b-f93e-4331-ace3-e2d232051cf7.jpg?guru_height=854&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/b4c49-6ca0ab1b-f93e-4331-ace3-e2d232051cf7.jpg?guru_height=854&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/962278","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["301089","300584","300630","301060","603122","300639","BK0042","BK0046","BK0132","BK0250","300642","002370","BK0239","BK0236"],"gpt_icon":0},{"id":"2462690337","title":"A股猴痘概念早盘冲高,亚太药业、合富中国拉升涨停,海辰药业涨超10%,透景生命、拓新药业、普利制药、科华生物等跟涨。消息面上,世卫组织启动全球战略准备和应对计划,以遏制猴痘疫情蔓延。","url":"https://stock-news.laohu8.com/highlight/detail?id=2462690337","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462690337?lang=zh_cn&edition=full","pubTime":"2024-08-27 09:34","pubTimestamp":1724722486,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["603122","BK0188","399300","BK0028","300642","BK0046","159982","BK0042","301089","300630","BK0132","002022","002370","BK0239","BK0250","300584"],"gpt_icon":0},{"id":"2462695980","title":"拓新药业(301089)2024年中报简析:净利润减100.57%,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2462695980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462695980?lang=zh_cn&edition=full","pubTime":"2024-08-25 06:13","pubTimestamp":1724537596,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期拓新药业发布2024年中报。截至本报告期末,公司营业总收入2.19亿元,同比下降66.7%,归母净利润-177.93万元,同比下降100.57%。本报告期拓新药业三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达122.07%。筹资活动产生的现金流量净额变动幅度为65.18%,原因:偿还银行贷款、现金分红较上期减少。去年的净利率为29.09%,算上全部成本后,公司产品或服务的附加值高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082500000888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301089"],"gpt_icon":0},{"id":"2461827146","title":"拓新药业(301089)8月9日股东户数2.17万户,较上期减少6.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461827146","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461827146?lang=zh_cn&edition=full","pubTime":"2024-08-24 17:05","pubTimestamp":1724490303,"startTime":"0","endTime":"0","summary":"证券之星消息,近日拓新药业披露,截至2024年8月9日公司股东户数为2.17万户,较6月30日减少1428.0户,减幅为6.17%。在化学制药行业个股中,拓新药业股东户数低于行业平均水平,截至8月9日,化学制药行业平均股东户数为3.23万户。从股价来看,2024年6月30日至2024年8月9日,拓新药业区间涨幅为6.17%,在此期间股东户数减少1428.0户,减幅为6.17%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082400009775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301089","BK0239"],"gpt_icon":0},{"id":"2461533543","title":"图解拓新药业中报:第二季度单季净利润同比减173.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461533543","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461533543?lang=zh_cn&edition=full","pubTime":"2024-08-24 01:29","pubTimestamp":1724434190,"startTime":"0","endTime":"0","summary":"证券之星消息,拓新药业2024年中报显示,公司主营收入2.19亿元,同比下降66.7%;归母净利润-177.93万元,同比下降100.57%;扣非净利润-796.7万元,同比下降102.62%;其中2024年第二季度,公司单季度主营收入1.1亿元,同比上升4.21%;单季度归母净利润-384.77万元,同比下降173.62%;单季度扣非净利润-732.56万元,同比下降549.5%;负债率11.24%,投资收益195.38万元,财务费用-238.69万元,毛利率24.55%。财报数据概要请见下图: 以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082400001877.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301089"],"gpt_icon":0},{"id":"2461591302","title":"拓新药业(301089.SZ)发布上半年业绩,净亏损177.93万元,由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2461591302","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461591302?lang=zh_cn&edition=full","pubTime":"2024-08-23 21:15","pubTimestamp":1724418922,"startTime":"0","endTime":"0","summary":"拓新药业(301089.SZ)发布2024年半年度报告,公司营业收入2.19亿元,...","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/25.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/25.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1169882.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["301089","BK0239"],"gpt_icon":0},{"id":"2461617596","title":"拓新药业最新公告:2024年上半年净利润亏损177.93万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461617596","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461617596?lang=zh_cn&edition=full","pubTime":"2024-08-23 20:50","pubTimestamp":1724417434,"startTime":"0","endTime":"0","summary":"拓新药业发布2024年半年度报告。报告期内,公司实现营业收入2.19亿元,同比下降66.70%;归属于上市公司股东的净利润为-177.93万元;基本每股收益为-0.01元。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082300046458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301089"],"gpt_icon":0},{"id":"2459121340","title":"拓新药业:公司产品四乙酰核糖、烟酰胺核苷(NR)可作为中间体,用于下游NMN的生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2459121340","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459121340?lang=zh_cn&edition=full","pubTime":"2024-08-14 19:02","pubTimestamp":1723633348,"startTime":"0","endTime":"0","summary":"证券之星消息,拓新药业08月14日在投资者关系平台上答复投资者关心的问题。谢谢拓新药业董秘:截至2024年8月9日,公司股东户数21,716户,感谢您的关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081400038982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301089","BK0239"],"gpt_icon":0},{"id":"2452400311","title":"09:25 三大指数集体低开,沪指低开0.4%,深成指低开0.84%,创业板指低开0.95% 09:28 智能驾驶、网约车概念股开盘下挫,锦江在线、星网宇达双双跌停,雷尔伟、安凯客车、金龙汽车、启明信息等跌幅居前 09:32 光刻机、光刻胶概念逆势走强,京华激光涨停,蓝英装备涨超10%,国林科技、芯源微、富创精密、张江高科等涨幅靠前 09:59 智能网约车概念探底回升,天迈科技涨近15%,此前兴民智通、龙江交通涨停,大众交通、动力新科、力帆科技、豪恩汽电涨幅靠前 09:59 创业板指拉升翻红,沪指、深成指跌幅有所收窄,光刻机、医药等方向涨幅居前,沪深京三市上涨个股近800只,宁德时代、中国移动、中国石化、比亚迪、迈瑞医疗等权重股冲高 10:14 医药医疗股震荡反弹,河化股份拉升封板,拓新药业涨超14%,海普瑞、粤万年青、同仁堂、康缘药业等跟涨 10:47 半导体芯片股震荡走低,淳中科技跌超8%,南芯科技、芯海科技、蓝箭电子、希荻微、力芯微、必易微、大为股份、德明利、兆易创新等十余股跌超6% 10:58 光伏、储能板块逆势活跃,阿特斯涨超10%,天宸股份此前涨停,上能电气、德业股份、仕净科技、锦浪科技涨幅靠前","url":"https://stock-news.laohu8.com/highlight/detail?id=2452400311","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452400311?lang=zh_cn&edition=full","pubTime":"2024-07-18 11:46","pubTimestamp":1721274382,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["300763","300786","301030","688484","603607","301348","09939","300750","301089","605117","301016","688601","002213","159938","399001","600841","09989","159982","000953","00285","601188","600895","300827","002594","601777","603516","300293","CHL","JKS","01211","688173","399006","002232","002399","688045","399300","600686","600611","001309","600085","000868","688409","300807","600941","688037","688472","300760","600557","301111","301488"],"gpt_icon":0},{"id":"2452149782","title":"医药医疗股震荡反弹,河化股份拉升封板,拓新药业涨超14%,海普瑞、粤万年青、同仁堂、康缘药业等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2452149782","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452149782?lang=zh_cn&edition=full","pubTime":"2024-07-18 10:14","pubTimestamp":1721268882,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK0097","BK0183","000953","BK0188","09989","BK1191","BK0196","BK0070","BK0077","BK1161","159938","600085","09939","BK0086","600557","BK0004","002399","BK0066","BK0113","BK0012","BK1515","301089","301111","LU1688375341.USD","BK1574","159891","BK0010","BK0071","BK0239","BK0028"],"gpt_icon":0},{"id":"2452651149","title":"新冠特效药概念明显异动,拓新药业一度冲板,海辰药业大涨8%,博瑞医药、红日药业、奥翔药业跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2452651149","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452651149?lang=zh_cn&edition=full","pubTime":"2024-07-18 10:06","pubTimestamp":1721268412,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["688166","300584","300026","BK0077","BK0239","301089","BK0188","603229"],"gpt_icon":0},{"id":"2449775367","title":"拓新药业:公司2024年6月28日股东人数请您届时查看公司2024年半年度报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2449775367","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449775367?lang=zh_cn&edition=full","pubTime":"2024-07-08 19:01","pubTimestamp":1720436494,"startTime":"0","endTime":"0","summary":"证券之星消息,拓新药业07月08日在投资者关系平台上答复投资者关心的问题。谢谢拓新药业董秘:公司2024年6月28日股东人数请您届时查看公司2024年半年度报告,感谢您的关注!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800025826.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301089","BK0239"],"gpt_icon":0},{"id":"2446669063","title":"拓新药业:截至2024年6月20日,公司股东户数22,784户","url":"https://stock-news.laohu8.com/highlight/detail?id=2446669063","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446669063?lang=zh_cn&edition=full","pubTime":"2024-06-26 19:01","pubTimestamp":1719399684,"startTime":"0","endTime":"0","summary":"证券之星消息,拓新药业(301089)06月26日在投资者关系平台上答复投资者关心的问题。投资者:第二季度业绩如何?有没有被st的可能?拓新药业董秘:具体业绩情况请您关注公司定期报告。感谢您的关注!投资者:请问截止到2024年6月20日公司收盘股东人数是多少?谢谢拓新药业董秘:截至2024年6月20日,公司股东户数22,784户。感谢您的关注!以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062600037502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301089","BK0239"],"gpt_icon":0},{"id":"2440248466","title":"拓新药业:截至2024年5月31日,公司股东户数22,702户","url":"https://stock-news.laohu8.com/highlight/detail?id=2440248466","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440248466?lang=zh_cn&edition=full","pubTime":"2024-06-03 19:01","pubTimestamp":1717412499,"startTime":"0","endTime":"0","summary":"证券之星消息,拓新药业(301089)06月03日在投资者关系平台上答复投资者关心的问题。投资者:请问最新的股东户数是多少?拓新药业董秘:截至2024年5月31日,公司股东户数22,702户。感谢您的关注!投资者:请问截止至2024年5月31日公司股东人数总数是多少?谢谢拓新药业董秘:截至2024年5月31日,公司股东户数22,702户。感谢您的关注!以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060300023960.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301089","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-10-27","address":"河南省新乡市红旗区高新区科隆大道515号","stockEarnings":[{"period":"1week","weight":-0.0092},{"period":"1month","weight":-0.0456},{"period":"3month","weight":0.0294},{"period":"6month","weight":-0.2153},{"period":"1year","weight":-0.3643},{"period":"ytd","weight":-0.3794}],"companyName":"拓新药业集团股份有限公司","boardCode":"AI0027","perCapita":"4742股","boardName":"医药制造业","registeredCapital":"12654万元","compareEarnings":[{"period":"1week","weight":0.0306},{"period":"1month","weight":0.0151},{"period":"3month","weight":0.1802},{"period":"6month","weight":0.0738},{"period":"1year","weight":0.1074},{"period":"ytd","weight":0.1385}],"survey":" 拓新药业集团股份有限公司是集化学合成、生物发酵核苷(酸)类原料药及医药中间体的研发、生产及销售为一体的高新技术企业。主要产品有嘧啶系列、嘌呤系列、核苷酸系列、核苷系列等多个系列核苷(酸)类产品,包括胞磷胆碱钠、利巴韦林、肌苷、阿昔洛韦、胞嘧啶、5-氟胞嘧啶、胞苷等原料药及医药中间体,主要涵盖抗病毒、抗肿瘤和神经系统用药领域。被认定为“国家高技术产业示范工程”,获得国家科学技术进步二等奖等重大科技奖项。公司及子公司已获得境内授权专利 9 项。","serverTime":1730840171596,"listedPrice":19.11,"stockholders":"19183人(较上一季度减少2.70%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"拓新药业(301089)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供拓新药业(301089)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"拓新药业,301089,拓新药业股票,拓新药业股票老虎,拓新药业股票老虎国际,拓新药业行情,拓新药业股票行情,拓新药业股价,拓新药业股市,拓新药业股票价格,拓新药业股票交易,拓新药业股票购买,拓新药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"拓新药业(301089)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供拓新药业(301089)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}